Your browser doesn't support javascript.
loading
Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study.
Deng, Lucy; Tapper, Kathryn; Thosar, Deepali; Goeman, Emma; Baker, Louise; Adelstein, Stephen; Boyle, Michael; Brown, David A; Evans, Louise; Katelaris, Connie; Lee, Frederick; Li, Jamma; Swaminathan, Sanjay; Taylor, Mark S; Wong, Melanie; Wood, Nicholas.
Afiliação
  • Deng L; National Centre for Immunisation Research and Surveillance, Children's Hospital at Westmead, Westmead, Australia; The University of Sydney Children's Hospital Westmead Clinical School, Westmead, Australia. Electronic address: lucy.deng@health.nsw.gov.au.
  • Tapper K; National Centre for Immunisation Research and Surveillance, Children's Hospital at Westmead, Westmead, Australia.
  • Thosar D; National Centre for Immunisation Research and Surveillance, Children's Hospital at Westmead, Westmead, Australia.
  • Goeman E; National Centre for Immunisation Research and Surveillance, Children's Hospital at Westmead, Westmead, Australia; The University of Sydney Children's Hospital Westmead Clinical School, Westmead, Australia.
  • Baker L; New South Wales Ministry of Health, St Leonards, New South Wales, Australia.
  • Adelstein S; Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Camperdown, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Boyle M; Department of Immunology, John Hunter Hospital, New Lambton Heights, Australia.
  • Brown DA; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Westmead, Australia; Department of Clinical Immunology, Westmead Hospital, Westmead, Australia; The University of Sydney Westmead Clinical School, Westmead, Australia.
  • Evans L; Department of Clinical Immunology, Allergy and HIV, Liverpool Hospital, Liverpool, Australia.
  • Katelaris C; Department of Clinical Immunology, Allergy and HIV, Liverpool Hospital, Liverpool, Australia; Department of Immunology and Allergy, Campbelltown Hospital, Campbelltown, Australia.
  • Lee F; Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Camperdown, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Li J; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, St Leonards, Australia; The University of Sydney Northern Clinical School, St Leonards, Australia.
  • Swaminathan S; The University of Sydney Westmead Clinical School, Westmead, Australia; School of Medicine, Western Sydney University, Australia; Department of Clinical Immunology and Allergy, Western Sydney Local Health District, Australia.
  • Taylor MS; Department of Clinical Immunology, Allergy and HIV, Liverpool Hospital, Liverpool, Australia; Department of Clinical Immunology, Prince of Wales Hospital, Randwick, Australia; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
  • Wong M; Department of Allergy and Immunology, Children's Hospital at Westmead, Westmead, Australia.
  • Wood N; National Centre for Immunisation Research and Surveillance, Children's Hospital at Westmead, Westmead, Australia; The University of Sydney Children's Hospital Westmead Clinical School, Westmead, Australia.
Vaccine ; 41(41): 5987-5993, 2023 09 22.
Article em En | MEDLINE | ID: mdl-37633752
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Anafilaxia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Anafilaxia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article